| # | Drug | Count |
|---|---|---|
| 0 | MYCOPHENOLATE MOFETIL | 113 |
| 1 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 113 |
| 2 | TACROLIMUS | 102 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 94 |
| 4 | TACROLIMUS OINTMENT 0.1% | 94 |
| 5 | VALGANCICLOVIR | 93 |
| 6 | VALGANCICLOVIR HYDROCHLORIDE | 93 |
| 7 | PREDNISONE | 87 |
| 8 | VALGANCICLOVIR HYDROCHLORIDE POWDER, | 80 |
| 9 | PREDNISOLONE | 64 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BRINCIDOFOVIR | 2 | 0.0144 |
| 1 | BEZLOTOXUMAB | 4 | 0.0114 |
| 2 | VALGANCICLOVIR | 93 | 0.0049 |
| 3 | FOSCARNET SODIUM | 19 | 0.0047 |
| 4 | GANCICLOVIR SODIUM | 45 | 0.0042 |
| 5 | MARIBAVIR | 9 | 0.0036 |
| 6 | BELATACEPT | 16 | 0.0034 |
| 7 | BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE | 3 | 0.0026 |
| 8 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 18 | 0.0022 |
| 9 | BASILIXIMAB | 17 | 0.0014 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 102 | 0.0046 |
| 1 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 9 | 0.0036 |
| 2 | Selective T Cell Costimulation Blocker [EPC] | 16 | 0.0034 |
| 3 | Macrolide Antibacterial [EPC] | 3 | 0.0030 |
| 4 | Nucleoside Analog Antiviral [EPC] | 44 | 0.0005 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 9 | 0.0004 |
| 6 | Lipid-based Polyene Antifungal [EPC] | 4 | 0.0003 |
| 7 | Somatostatin Analog [EPC] | 2 | 0.0003 |
| 8 | Rifamycin Antimycobacterial [EPC] | 1 | 0.0003 |
| 9 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |